SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling

The immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteome is largely unknown. Here we describe a protocol for analyzing sera samples with SARS-CoV-2 proteome microarray. The proteins were expressed by either E. coli expression system or eukaryotic cell expression sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Dan-yun, Jiang, He-wei, Li, Yang, Zhang, Hai-nan, Tao, Sheng-ce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882418/
https://www.ncbi.nlm.nih.gov/pubmed/35310073
http://dx.doi.org/10.1016/j.xpro.2022.101238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882418/
https://www.ncbi.nlm.nih.gov/pubmed/35310073
http://dx.doi.org/10.1016/j.xpro.2022.101238

Ejemplares similares